4 trends tracked about this subject — the full history, oldest to newest below.
Merck is securing global access and generic licensing for a first-of-its-kind monthly oral HIV prevention pill ahead of its official approval.
Prediction platform Kalshi is launching sports-style betting markets focused on biotech clinical trials and FDA drug approvals.
The FDA has approved a first-of-its-kind cholesterol pill from Merck designed to drive cholesterol levels lower than statins.
A US House committee has launched an investigation into Merck and AbbVie regarding drug trials conducted in China.